Summary. Chromogranins (Cg) are large acidic proteins, co-stored with amines or peptides in the secretory granules of a wide variety of paraneurons. By immunohistochemistry performed on serial semithin sections, the distribution of Cg in the gastroenteropancreatic (GEP) system was analyzed in the endocrine pancreas of 10 mammalian species and in enteroendocrine cells of 6 species. Of the Cg families, CgA is primarily localized in GEP endocrine cells. CgA was regularly present in amine containing cells (EC and EC-like cells). In 11 other endocrine cell types, CgA-immunoreactivities showed inter-species and intra-species variations in their distribution or in the intensity of staining. However, no endocrine cell type lacked CgA-immunoreactivities in all species investigated.
Findings from extended studies indicate that CgA is involved in the intracellular storage of resident amines, and in the storage of newly formed amines after exogenous application of the corresponding precursors. Finally, densitometric findings on possible reciprocal relationships between CgA-and peptide-immunoreactivities suggest that CgA also participates in the intragranular storage of peptide hormones in certain GEP endocrine cells.
The chromogranins (Cg), constituting a group of large acidic proteins, were originally detected in the secretion granules of adrenal medullary cells where they are co-stored with amines and peptides. These proteins are made up of three families, denominated as : chromogranin A (CgA), chromogranin B (CgB), and secretogranin II (Sg II) (see WINKLER et al., 1986; EIDEN et al., 1987; FISCHER-COLBRIE and SCHOBER, 1987) . The proposed functions of Cg include the organization of the granule matrix (e.g. binding of calcium), the processing or packaging of peptide hormones or their precursors, and possible regulatory functions after secretion (WINKLER et al., 1986; KONECKI et al., 1987) .
Cg have been found in many locations outside the adrenal medulla (O'CONNOR, 1983; O'CONNOR et al., 1983; HAGN et al.. 1986; RINDI et al., 1986; review; FUJITA et al., 1988) . Presumably, they are regularly present in neurons and peptide hormone-producing cells. Within the gastroenteropancreatic (GEP) system, Cg have been found in endocrine cells as constituents of the secretion granules (VARNDELL et al., 1985; EHRHART et al., 1986) . Interestingly, pancreastatin, a newly discovered pancreatic hormone which inhibits insulin secretion, is closely related to CgA (TATEMOTO et al., 1986; KONECKI et al., 1987) . Therefore, it is speculated that Cg function also as precursors of other enteric hormones yet to be identified.
During the past 4 years, we have investigated immunohistochemically the distribution of Cg in the mammalian GEP endocrine system, including certain aspects related to the possible functions of Cg in this cellular community.
The present review will deal with 4 pertinent areas:
1. Comments on the immunohistochemical proof of Cg.
2. Cellular localization of Cg in the mammalian GEP endocrine system.
3. Interrelations of CgA with amine metabolism in enteroendocrine cells.
4. Interrelations of CgA with peptides in certain GEP endocrine cells.
IMMUNOHISTOCHEMISTRY OF CHROMO-GRAINS
The outcome of immunohistochemical stainings depends on many factors. Essentials of success include the specificities or crossreactivities of the antibodies, the methods of tissue preparation (fixation, embedding), and the immunohistochemical method or certain steps of the respective protocol (STERNBERGER,1986) .
Concerning the immunohistochemistry
of Cg, a comparison of findings as published by different laboratories is problematical for the following reasons: At present, more than 15 monoclonal or polyclonal antisera against Cg and related proteins are used (see GRUBS et al.,1986; RINDI et al., 1986) . These antisera are raised against different antigens of various mammals (crude or purified extracts from normal tissues and neoplastic growths). For the immunohistochemical proof of Cg, various fixatives have turned out to be less than suitable or even inappropriate RINDI et al., 1986) . Within a well-established immunohistochemical protocol, the dilution of the antisera and even the type of buffer used may lead to misleading results, e.g., false-positive or false-negative stainings YOSHIE et al., 1987) .
To exclude at least some of these factors, our findings, specified below, refer to studies performed by identical methods. We used a limited number of polyclonal antisera against bovine and rat Cg (source: D. Aunis, Strasbourg, France; H. Winkler, Innsbruck, Austria) that have been characterized immunologically and immunohistochemically (EHRHART et al., 1986 (EHRHART et al., , 1988 HAGN et al., 1986; FISCHER-COLBRIE and SCHOBER, 1987; YOSHIE et al., 1987; BARGSTEN et al., 1988) . The tissues under study and reference organs were prepared by identical, established methods (GRUBE and KUSUMOTO, 1986) . Throughout all studies, the peroxidase anti-peroxidase (PAP) technique (STERNBERGER, 1986) was applied according to generally standardized protocol (GRUBE and KUSUMOTO, 1986) . Our investigations were done on serial semithin (0.5um) sections, alternatively immunostained for Cg and amines or peptides. Thus, endocrine cells immunoreactive for Cg could be clearly identified. Moreover, immunoreactivities in semithin sections can be quantified or compared, with immunoreactive cells serving for reference (GRUBE and KUSUMOTO, 1986; EHRHART et al., 1988) .
DISTRIBUTION OF CHROMOGRANINS
Of the antisera applied, the CgA antiserum Europium, raised against bovine CgA (D. Aunis), showed the highest titer. Even when diluted 1:64,000, this antiserum immunostained bovine endocrine cells (EHRHART et al., 1986; . Most of our studies were performed using this antiserum. The distribution of other Cg (CgB, Sg II) as yet has been studied only in certain species or locations (see below).
In the GEP system, immunoreactivities for Cg were exclusively found in endocrine cells. In contrast to the findings of some other authors, we found no CgAimmunoreactivities in nerve cells, lymphatic tissue, or wandering cells of the connective tissue.
CgA in GEP endocrine cells Upon screening the GEP endocrine cells of different species for their CgA-immunoreactivities, two basic observations were readily made. Firstly, crossreactivities of the CgA antibodies vary among the species; therefore, CgA-immunoreactivities in some species were only recognized when also less-diluted antisera were used (Figs. l-4) . Secondly, CgA-immunoreactivities are largely heterogeneous; they show expressed interspecies and intra-species differences with respect to the immunoreactive cell types and the intensities of staining.
The cellular localization of CgA was studied in five pancreatic endocrine cell types (B, A, D, PP, EC cells) from ten mammalian species (man, tupaia, mole, pig, cat, dog, cattle, guinea-pig, rabbit, rat), and in ten enteroendocrine cell types (EC, EC-like, G, CCK, D, S, Mo, N, GIP, PYY cells) from six species (man, pig, cat, cattle, guinea-pig, rat). GEP endocrine cells of the dog and rabbit showed only weak immunoreactivities towards the antiserum raised against bovine CgA; rat GEP endocrine cells were completely negative. These latter cells, however, could be immunostained by an antiserum raised against rat CgA (Fig.  5) .
Endocrine cells containing serotonin or histamine (EC and EC-like cells) were heavily immunoreactive for CgA (Fig. 6c) . In contrast, mast cells, another source of histamine (or, in some species, also of serotonin) were negative for CgA. All other GEP endocrine cells, identified by their resident peptides on adjacent semithin sections, varied considerably with respect to their CgA-immunoreactivities. Both pancreatic endocrine cells (Figs. l-4 ) and enteroendocrine cells showed inter-species differences in their CgA-immunoreactivities.
In none of the species studied were GEP endocrine cells concomitantly CgAimmunoreactive. On the other hand, no endocrine cell type lacked CgA-immunoreactivity in any species. Other heterogeneities of CgA-immunoreactivities, seen in the same species, refer to inter-cellular differences among endocrine cells of the same population. Thus, endocrine cells common to the pancreas and gastrointestinal tract (e.g. D cells) may be CgA-positive in one location and CgA-negative in another. Similar differences were observed with respect to the intensities of staining, and also between the various gastrointestinal segments. Finally, also within the same location, endocrine cells of the same population showed differences in the degree of their CgA-immunoreactivities (Figs. 1-7) .
In consequence of these findings, and for practical purposes, the presence (or absence) of CgA-immunoreactivity in an endocrine cell of a certain species or in a certain location should not be categorized.
The reasons for the heterogeneities observed so far remain enigmatic. We speculate that the different CgA-immunoreactivities reflect differences in the intra-cellular processing of CgA, or that the densities of immunostainings are influenced by the quantity of co-stored peptides (see below).
Other Cg in GEP endocrine cells Thus far, immunoreactivities of GEP endocrine cells for CgB have been studied only in some species (see also HAGN et al., 1986; RINDI et al., 1986) . In the endocrine pancreas, CgB-immunoreactivities in general are of low intensity. In enteroendocrine cells, CgB-immunoreactivities are restricted to certain endocrine cells, exhibiting inter-species or intercellular differences in their distribution (Fig. 6) . Sg IIimmunoreactivities are only rarely found in enteroendocrine cells. In the bovine endocrine pancreas, Sg II shows a peculiar localization, mainly to PP cells (YOSHIE et al., 1987) .
INTERRELATIONS OF CGA WITH BIOGENIC MONOAMINES
The regular co-localization of CgA and amines in some GEP endocrine cells points to a possible interrelation for these substances at the subcellular level (see also WINKLER et al., 1986) . Since most of the other Figs. 1-4. Inter-species variations of CgA-like immunoreactivities in the mammalian endocrine pancreas. Semithin sections were immunostained for CgA using antiserum dilutions of 1: 32,000 (1), 1: 16,000 (2), 1: 4,000 (3), and 1: 2,000 (4). CgA-immunoreactive endocrine cells were identified in appropriately immunostained adjacent sections (not shown). In the bovine pancreas (1), CgA-immunoreactivity is mainly localized to B cells, in the human pancreas (2) to A cells, in the guinea-pig pancreas (3) to B and PP cells, and in the feline pancreas GEP endocrine cells without a primary content of amines are able to store amines after exogenous application of the corresponding precursors (APUD cells; PEARSE, 1969) , it is reasonable to assume that this secondary or facultative content of amines is also related to their respective CgA-immunoreactivities. Therefore, we experimentally investigated the enteroendocrine cells of the rat and guinea-pig after the exogenous application of 5-hydroxytryptophan (5HTP) or di-hydroxyphenylalanine (DOPA), the precursors of 5-hydroxytryptamine (5-HT or serotonin) and dopamine (DA).
In the rat stomach, after 5-HTP-loading of the animals, numerous endocrine cells show serotoninimmunoreactivities.
Comparison of 5-HT-immunoreactivities with CgA-immunoreactivities of the same cells revealed a complete coincidence of serotonin and CgA; even the intensities of either immunoreactivity were identical. Most of these cells with a secondary content of 5-HT were identified as G cells. Relationships between CgA-immunoreactivities and the primary and secondary content of amines, and the distribution of CgB in enteroendocrine cells. A guinea-pig was injected with 100mg/kg DOPA, 90min prior to killing. Four serial semithin sections through the pyloric mucosa were immunostained for dopamine. (DA; a), gastrin (GAS; b), CgA (CGA; c), and CgB (CGB; d). An EC cell (identified in an appropriately immunostained adjacent section, not shown) is immunoreactive for CgA, unreactive for CgB, and faintly immunoreactive for DA (arrow-heads in a, c, d). In gastrin cells, the DA-content parallels CgA-immunoreactivities, only some of which are also CgB-immunoreactive (arrows). x590
Inversely, endocrine cells lacking CgA-immunoreactivities in this location (e.g. D cells) showed no secondary content of serotonin (Fig. 5) . Similar findings were obtained in the pyloric region of the guinea-pig stomach after exogenous application of DOPA. Here, DA is mainly localized to cells identified as G cells (Fig. 6) . Again, the immunoreactivities for CgA and the newly stored amine are identically localized. Interestingly, and confirming previous findings on this subject obtained in the rat (GRUBE, 1976) , EC cells under these conditions lacked any DA or showed only a very faint staining for DA (Fig. 6) . Hence, EC cells either have selective mechanisms for the uptake of different amine precursors, or the binding sites for amines in these cells physiologically are occupied, preventing the storage of an Fig. 7 a and GRUBE, 1976 . The secondary content of amines in these endocrine cells could merely be a kind of supravital staining, caused by the presence of appropriately charged intragranular binding sites (CgA). Additionally, other histochemical properties of GEP endocrine cells (e.g. supravital staining by neutral red, empirical histological staining characteristics, nonspecific binding of IgG molecules in immunohistochemistry) could be attributed to the presence of these negatively charged proteins in the secretory granules which bind positively charged physiological and non-physiological compounds FU-JITA et al., 1988) .
INTERRELATIONS OF CGA WITH PEPTIDE HORMONES
During previous immunohistochemical investigations of CgA in mammalian GEP endocrine cells, we found repeatedly an inverse relationship between the densities of CgA-and peptide-immunoreactivities in certain endocrine cells, e.g. in bovine and feline B cells, rat G cells, and human A cells . This possible interrelation of CgA and peptide hormones within the same endocrine cells is currently being more closely investigated in human pancreatic A cells and in guinea-pig gastric G cells. In series of paired semithin sections immunostained alternatively for CgA and glucagon or gastrin by highly diluted antisera, the densities of the respective immunoreactivities are being compared. In some G cells (Fig. 6 ) and some A cells (Fig. 7) an inverse relation between CgA-and peptide-immunoreactivities can already be subjectively discerned. Minor differences, however, escape attention, mainly because the differences between high and low staining intensities for gastrin or glucagon are not as evident as those for CgA. To detect less expressed differences in the intensities of staining, analyses by optical density measurements are a suitable tool (Interactive Image Analyzing System I. B. A. S., ZeissKontron, Germany; see GRUBE and KUSUMOTO, 1986; EHRHART et al., 1988) . According to the findings so far obtained in G and A cells, a relatively high proportion of these cells exhibits this reciprocal relation between CgA-and peptide-immunoreactivities.
Although preliminary, these findings indicate relationships between the peptide and CgA metabolism in GEP endocrine cells.
Theoretically, the differences in the intensities of staining could give insight into the relative concentrations of the cellular antigens (STERNBERGER,1986), or they may reflect differences in crossreactivities between the antibodies and the corresponding antigens. Presumably, both reasons overlap or are appropriate for CgA-and peptide-immunoreactivities for different causes. To interpret our findings, we have the following working hypothesis:
the members of a given endocrine cell population differ in their actual functional state and, hence, in their peptide content. In immunohistochemistry, the relative concentration of the peptide is represented by the density of its immunoreactivity.
Peptides are stored in the granules together with CgA and other proteins. A high amount of stored peptides leads to steric hindrances, resulting in a masking of the CgA epitopes which then bind CgA antibodies to a lesser degree or by minor avidity.
In consequence, we hypothesize that the intensity of staining for CgA in certain CgA-immunoreactive endocrine cells is an indicator of their actual metabolic state. Extended densitometric analyses of endocrine cells, also under experimental conditions, are necessary to further investigate this problem. Following this, our immunohistochemical findings can possibly be correlated to those obtained from biochemical investigations (HUTTON et al., 1987) of the relationships between the metabolism of peptides and Cg-related proteins in GEP endocrine cells.
